Search results
Mar 13, 2019 · The onset of a morbilliform eruption (MDE; also known as exanthematous or maculopapular drug eruption) typically occurs within 7 to 10 days after the initiation of the culprit drug. Occasionally a 14-day window has been noted. On rechallenge with a drug that the patient has been sensitized to in the past, the eruption may occur within 24 hours.
Jan 30, 2023 · On day four, the eosinophil count increased to 11.2%. This was accompanied by the evolution of the papular rash, becoming confluent and morbilliform over her abdomen and back (Figures (Figures3, 3, ,4). 4). Management included discontinuation of all culprit drugs and symptomatic management with intravenous fluids and supplemental oxygen as needed.
Jan 12, 2023 · INTRODUCTION. Exanthematous (maculopapular) drug eruption, also called morbilliform (measles-like) drug-induced exanthem, is the most common drug hypersensitivity reaction [ 1,2 ]. It is characterized by a disseminated, and occasionally generalized, symmetric eruption of erythematous macules and/or papules ( picture 1A-B) that occur ...
Side effects of metals and metal antagonists. Joshua P. Gray PhD, Sidhartha D. Ray PhD, FACN, in Side Effects of Drugs Annual, 2023 Immunologic. An urticated morbilliform eruption and conjunctival injection occurred in a 29-year-old woman treated with penicillamine for Wilson's disease for the previous 10 days (250 mg, 4 times daily) (Pham et al., 2022) [A].
Nov 14, 2023 · The term maculopapular rash typically implies an acute and generalized eruption. Morphologic terms. Macule: a flat, circumscribed skin lesion ≤1 cm in greatest diameter. When macules are >1 cm, the appropriate term is patch. Papule: an elevated, circumscribed skin lesion ≤1 cm in diameter. When papules are >1 cm in size, the appropriate ...
Immunology, dermatology. Drug rash with eosinophilia and systemic symptoms or drug reaction with eosinophilia and systemic symptoms ( DRESS ), also termed drug-induced hypersensitivity syndrome ( DIHS ), is a rare reaction to certain medications. It involves primarily a widespread skin rash, fever, swollen lymph nodes, and characteristic blood ...
Cutaneous manifestations of COVID-19 are characteristic signs or symptoms of the Coronavirus disease 2019 that occur in the skin. The American Academy of Dermatology reports that skin lesions such as morbilliform (measles-like rashes, 22%), pernio (capillary damage, 18%), urticaria (hives, 16%), macular erythema (rose-colored rash, 13%), vesicular purpura (purplish discolouration, 11% ...
